Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia

被引:0
|
作者
Isoe, K [1 ]
Urakami, K [1 ]
Sato, K [1 ]
Takahashi, K [1 ]
机构
[1] TOTTORI UNIV,FAC MED,INST LIFE SCI,DEPT BIOL MOLEC,YONAGO,TOTTORI 683,JAPAN
来源
ACTA NEUROLOGICA SCANDINAVICA | 1996年 / 93卷 / 2-3期
关键词
dementia of the Alzheimer type; vascular dementia; apolipoprotein E; skin fibroblast;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The phenotypes of apolioprotein E (ApoE) in the plasma of patients with dementia of the Alzheimer type (DAT) and vascular dementia (VD) were determined by the isoelectric focusing method. The ApoE mRNA level in the skin fibroblasts was also determined by the Northern blot analysis. As compared with the control subjects, the frequency of the ApoE epsilon 4 allele was significantly higher in the DAT group as well as the VD group, but was not significantly different in the cerebrovascular disease without dementia (CVD) group. The skin fibroblast ApoE mRNA level in the DAT group and the VD group was significantly lower than that in the control group. These findings suggest that the phenotype of ApoE is associated with DAT and VD, and that the lower level of ApoE mRNA may play an important role in the development of DAT as well as VD.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 50 条
  • [31] Neuropsychological pattern of cognitive impairment in Alzheimer type dementia and vascular dementia
    Marcos, T
    Salamero, M
    de Azpiazu, P
    Pujol, J
    Beget, T
    Peri, JM
    Lázaro, ML
    MEDICINA CLINICA, 2000, 114 (15): : 566 - 570
  • [32] A comparison of semantic memory in vascular dementia and dementia of Alzheimer's type
    Bentham, PW
    Jones, S
    Hodges, JR
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1997, 12 (05) : 575 - 580
  • [33] Vascular dementia or dementia of Alzheimer's type: The clinical differentiation.
    Fischer, P
    NEUROPSYCHIATRIE, 1996, 10 (03): : 123 - 125
  • [34] Apolipoprotein E (ApoE) phenotype in Alzheimer's disease, vascular dementia and Parkinson's disease with and without dementia in Northern Ireland
    Foy, CJ
    Passmore, AP
    Vahidassr, DM
    Young, IS
    Smye, M
    Lawson, JT
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 805 - 810
  • [35] Incidence rates of dementia, Alzheimer's disease and vascular dementia in The Kame Project: Roles of age, gender, education and apolipoprotein E
    Graves, AB
    Wu, YG
    McCormick, W
    Bowen, JD
    McCurry, S
    Larson, EB
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S419 - S419
  • [36] Risk factors and type of dementia: Vascular or Alzheimer?
    Cankurtaran, Mustafa
    Yavuz, Burcu Balam
    Cankurtaran, Eylem Sahin
    Halil, Meltem
    Ulger, Zekeriya
    Ariogul, Servet
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2008, 47 (01) : 25 - 34
  • [37] The role of the polymorphic genes apolipoprotein E and methylenetetrahydrofolate reductase in the development of dementia of the Alzheimer type
    Regland, B
    Blennow, K
    Germgård, T
    Koch-Schmidt, AC
    Gottfries, CG
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (04) : 245 - 251
  • [38] Apolipoprotein E polymorphism in ischemic cerebrovascular diseases and vascular dementia patients in Taiwan
    Lin, HF
    Lai, CL
    Tai, CT
    Lin, RT
    Liu, CK
    NEUROEPIDEMIOLOGY, 2004, 23 (03) : 129 - 134
  • [39] Apolipoprotein E genotype and risk of ischemic cerebrovascular disease, Alzheimer's disease, and vascular dementia
    Frikke-Schmidt, R
    Nordestgaard, BG
    Thudium, D
    Groenholdt, MLM
    Tybjaerg-Hansen, A
    CIRCULATION, 1999, 100 (18) : 532 - 532
  • [40] No association between α1-antichymotrypsin and apolipoprotein E in Alzheimer's disease and vascular dementia
    Durany, N
    Cruz-Sánchez, FF
    Thome, J
    Höhn, H
    Retz, W
    Riederer, P
    Rösler, M
    ALZHEIMERS REPORTS, 1999, 2 (03): : 159 - 164